UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 186

Sortiert nach

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Journal of hematology and oncology, 2018-01, Vol.11 (1), p.15-15, Article 15

2018

Volltextzugriff (PDF)

Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma

Nature communications, 2019-09, Vol.10 (1), p.4209-14, Article 4209

2019

Volltextzugriff (PDF)

Ibrutinib combined with venetoclax for the treatment of relapsed/refractory diffuse large B cell lymphoma

Annals of hematology, 2021-06, Vol.100 (6), p.1509-1516

2021

Volltextzugriff (PDF)

Recurrent PDGFRB mutations in unicentric Castleman disease

Leukemia, 2019-04, Vol.33 (4), p.1035-1038

2019

Volltextzugriff (PDF)

TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway

Journal of translational medicine, 2018-01, Vol.16 (1), p.7-10, Article 7

2018

Volltextzugriff (PDF)

Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type

Frontiers in cellular and infection microbiology, 2021-09, Vol.11, p.686595-686595

2021

Volltextzugriff (PDF)

First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.3026-3026

2020

Volltextzugriff (PDF)

AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphoma

Molecular medicine (Cambridge, Mass.), 2018-07, Vol.24 (1), p.35-35, Article 35

2018

Volltextzugriff (PDF)

Elucidating osseointegration in vivo in 3D printed scaffolds eliciting different foreign body responses

Materials today bio, 2023-10, Vol.22, p.100771-100771, Article 100771

2023

Volltextzugriff (PDF)

Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma

Cancer Research and Treatment, 2021, 53(3), , pp.837-846

2021

Volltextzugriff (PDF)

Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma

Cancer medicine (Malden, MA), 2023-04, Vol.12 (7), p.8134-8143

2023

Volltextzugriff (PDF)

Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma

Haematologica (Roma), 2020-03, Vol.105 (3), p.e107

2020

Volltextzugriff (PDF)

Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure

Frontiers in oncology, 2021-06, Vol.11, p.687374-687374

2021

Volltextzugriff (PDF)

DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T‐cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients

Clinical and translational science, 2021-01, Vol.14 (1), p.405-411

2021

Volltextzugriff (PDF)

Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study

Indian journal of hematology & blood transfusion, 2022-01, Vol.38 (1), p.42-50

2022

Volltextzugriff (PDF)

Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial

Cancer biology & medicine, 2021-10, Vol.19 (7), p.1089-1099

2021

Volltextzugriff (PDF)

Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?

Cancer cell international, 2018-10, Vol.18 (1), p.150-150, Article 150

2018

Volltextzugriff (PDF)

Safety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma

Leukemia & lymphoma, 2015-01, Vol.56 (9), p.2613-2618

2015

Volltextzugriff (PDF)

Analysis of the Tumor Microenvironment By Quantitative Immunohistochemistry Reveals Novel Predictors in Classic Hodgkin Lymphoma Treated with Anti-PD1 Therapy

Blood, 2021-11, Vol.138 (Supplement 1), p.4530-4530

2021

Volltextzugriff (PDF)

Influence of organic sulfur gas-phase sulfation on the NH3-SCR activity of CeO2 catalyst: The competitive adsorption and conversion of CS2 and COS at a low hydrolysis temperature

Fuel (Guildford), 2024-05, Vol.364, p.131101, Article 131101

2024

Volltextzugriff (PDF)

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

Clinical cancer research, 2016-11, Vol.22 (21), p.5223-5228

2016

Volltextzugriff (PDF)

Autologous nanobody-derived fratricide-resistant CD7-CAR T cell therapy for patients with relapsed and refractory T-cell acute lymphoblastic leukemia/lymphoma

Clinical cancer research, 2022-07, Vol.28 (13), p.2830-2843

2022

Volltextzugriff (PDF)

CD5-positive marginal zone lymphoma: Clinicopathological features and survival outcomes

Leukemia research, 2022-06, Vol.117, p.106840-106840, Article 106840

2022

Volltextzugriff (PDF)

c‐Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T‐cell lymphoma

Journal of cellular biochemistry, 2019-08, Vol.120 (8), p.12628-12637

2019

Volltextzugriff (PDF)

A Phase I/II Study of Orelabrutinib Combined with Anti-Programmed Cell Death Protein-1 Antibody and Fotemustine for Patients with Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL)

Blood, 2022-11, Vol.140 (Supplement 1), p.12075-12076

2022

Volltextzugriff (PDF)

1 – 25 von 186

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(151)
Mit Volltextzugriff
(174)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(150)
Life Sciences & Biomedicine
(100)
Humans
(51)
Technology
(48)
Oncology
(43)
Computer Science
(31)
Lymphoma
(31)
Chemotherapy
(25)
Computer Science, Software Engineering
(22)
Female
(21)
Male
(21)
Patients
(21)
Engineering
(18)
Hematology
(18)
Adult
(17)
Middle Aged
(16)
Magnetic Resonance Imaging
(13)
Medical Prognosis
(13)
Prognosis
(12)
Retrospective Studies
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Recurrent GNAQ mutation encoding T96S in natural killer/T cell lymphoma

Ibrutinib combined with venetoclax for the treatment of relapsed/refractory diffuse large B cell lymphoma

Recurrent PDGFRB mutations in unicentric Castleman disease

TIPE2 suppresses progression and tumorigenesis of esophageal carcinoma via inhibition of the Wnt/β-catenin pathway

Characteristics and Clinical Implications of the Nasal Microbiota in Extranodal NK/T-Cell Lymphoma, Nasal Type

First-in-human clinical trial of the autologous CD7-CART for relapsed/refractory ACUTE lymphoblastic leukemia/lymphoma

AEG-1 is involved in hypoxia-induced autophagy and decreases chemosensitivity in T-cell lymphoma

Elucidating osseointegration in vivo in 3D printed scaffolds eliciting different foreign body responses

Baseline Total Metabolic Tumor Volume and Total Lesion Glycolysis Measured on 18F-FDG PET-CT Predict Outcomes in T-Cell Lymphoblastic Lymphoma

Decitabine combined with RDHAP regimen in relapsed/refractory diffuse large B cell lymphoma

Genomic and outcome analysis of adult T-cell lymphoblastic lymphoma

Combination of Decitabine and a Modified Regimen of Cisplatin, Cytarabine and Dexamethasone: A Potential Salvage Regimen for Relapsed or Refractory Diffuse Large B-Cell Lymphoma After Second-Line Treatment Failure

DDGP vs. SMILE in Relapsed/Refractory Extranodal Natural Killer/T‐cell Lymphoma, Nasal Type: A Retrospective Study of 54 Patients

Ibrutinib in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma: A Retrospective Study

Fotemustine-based therapy in combination with rituximab as a first-line induction chemotherapy followed by WBRT for newly diagnosed primary central nervous system lymphoma: a prospective phase II trial

Conserved cell populations in doxorubicin-resistant human nasal natural killer/T cell lymphoma cell line: super multidrug resistant cells?

Safety and efficacy of low-dose pre-phase before conventional-dose chemotherapy for ulcerative gastric diffuse large B-cell lymphoma

Analysis of the Tumor Microenvironment By Quantitative Immunohistochemistry Reveals Novel Predictors in Classic Hodgkin Lymphoma Treated with Anti-PD1 Therapy

Influence of organic sulfur gas-phase sulfation on the NH3-SCR activity of CeO2 catalyst: The competitive adsorption and conversion of CS2 and COS at a low hydrolysis temperature

DDGP versus SMILE in Newly Diagnosed Advanced Natural Killer/T-Cell Lymphoma: A Randomized Controlled, Multicenter, Open-label Study in China

Autologous nanobody-derived fratricide-resistant CD7-CAR T cell therapy for patients with relapsed and refractory T-cell acute lymphoblastic leukemia/lymphoma

CD5-positive marginal zone lymphoma: Clinicopathological features and survival outcomes

c‐Myc mediated upregulation of long noncoding RNA SNHG12 regulates proliferation and drug sensitivity in natural killer/T‐cell lymphoma

A Phase I/II Study of Orelabrutinib Combined with Anti-Programmed Cell Death Protein-1 Antibody and Fotemustine for Patients with Newly Diagnosed Primary Central Nervous System Lymphoma (PCNSL)

Suchergebnisse filtern